The effect of etanercept on lung leukocyte margination and fibrin deposition after cardiac surgery

American Journal of Respiratory and Critical Care Medicine

Volumn 188, Issue 6, 2013, Pages 751-754

  Dixon, Barry ^a   Smith, Roger ^a   Campbell, Duncan J ^b   Tobin, Antony ^a   Newcomb, Andrew E ^a   Rosalion, Alexander ^a   Opeskin, Kenneth ^a   Carter, Helen ^a   Scott, David A ^a   Santamaria, John D ^a  

^a ST VINCENT S HOSPITAL   (Australia)

^b ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ETANERCEPT; PLACEBO;

ACUTE LUNG INJURY; CARDIOPULMONARY BYPASS; DRUG DOSE ESCALATION; FIBRIN DEPOSITION; HEART SURGERY; HUMAN; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LETTER; LEUKOCYTE; LUNG BIOPSY; LUNG FUNCTION; LUNG INJURY; NONHUMAN; PRIORITY JOURNAL;

EID: 84884613081     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201301-0120LE     Document Type: Letter

References (15)

1. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 2000;342:1334-1349.
2. Chai PJ, Williamson JA, Lodge AJ, Daggett CW, Scarborough JE, Meliones JN, Cheifetz IM, Jaggers JJ, Ungerleider RM. Effects of ischemia on pulmonary dysfunction after cardiopulmonary bypass. Ann Thorac Surg 1999;67:731-735.
3. Dieleman JM, Nierich AP, Rosseel PM, van der Maaten JM, Hofland J, Diephuis JC, Schepp RM, Boer C, Moons KG, van Herwerden LA, et al.; Dexamethasone for Cardiac Surgery (DECS) Study Group. Intraoperative high-dose dexamethasone for cardiac surgery: a randomized controlled trial. JAMA 2012;308:1761-1767.
4. Bertok S, Wilson MR, Morley PJ, de Wildt R, Bayliffe A, Takata M. Selective inhibition of intra-alveolar p55 TNF receptor attenuates ventilatorinduced lung injury. Thorax 2012;67:244-251.
5. Davidson BA, Knight PR, Helinski JD, Nader ND, Shanley TP, Johnson KJ. The role of tumor necrosis factor-alpha in the pathogenesis of aspiration pneumonitis in rats. Anesthesiology 1999;91:486-499.
6. Zeng M, Zhang H, Lowell C, He P. Tumor necrosis factor-alpha-induced leukocyte adhesion and microvessel permeability. Am J Physiol Heart Circ Physiol 2002;283:H2420-H2430.
7. Vlaar AP, Hofstra JJ, Determann RM, Veelo DP, Paulus F, Levi M, Zeerleder S, Vroom MB, Schultz MJ, Juffermans NP. Transfusionrelated acute lung injury in cardiac surgery patients is characterized by pulmonary inflammation and coagulopathy: a prospective nested casecontrol study. Crit Care Med 2012;40:2813-2820.
8. van der Poll T, Coyle SM, Levi M, Jansen PM, Dentener M, Barbosa K, Buurman WA, Hack CE, ten Cate JW, Agosti JM, et al. Effect of a recombinant dimeric tumor necrosis factor receptor on inflammatory responses to intravenous endotoxin in normal humans. Blood 1997;89:3727-3734.
9. Blaisdell FW. Pathophysiology of the respiratory distress syndrome. Arch Surg 1974;108:44-49.
10. Tanaka K. [Specific inhibition of thrombin activity during cardiopulmonary bypass reduces ischemia-reperfusion injury of the lung]. [Published in Japanese] Fukuoka Igaku Zasshi 2001;92:7-20.
11. Pearson MJ, Lipowsky HH. Effect of fibrinogen on leukocyte margination and adhesion in postcapillary venules. Microcirculation 2004;11:295-306.
12. Burns AR, Smith CW, Walker DC. Unique structural features that influence neutrophil emigration into the lung. Physiol Rev 2003;83:309-336.
13. Tomashefski JF Jr, Davies P, Boggis C, Greene R, Zapol WM, Reid LM. The pulmonary vascular lesions of the adult respiratory distress syndrome. Am J Pathol 1983;112:112-126.
14. Dixon B, Opeskin K, Stamaratis G, Nixon I, Yi M, Newcomb AE, Rosalion A, Zhang Y, Santamaria JD, Campbell DJ. Pre-operative heparin reduces pulmonary microvascular fibrin deposition following cardiac surgery. Thromb Res 2011;127:e27-e30.
15. Dixon B, Schultz MJ, Smith R, Fink JB, Santamaria JD, Campbell DJ. Nebulized heparin is associated with fewer days of mechanical ventilation in critically ill patients: a randomized controlled trial. Crit Care 2010;14:R180.